UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 18, 2013

 

 

PSIVIDA CORP.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   000-51122   26-2774444

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

400 Pleasant Street

Watertown, MA 02472

(Address of Principal Executive Offices) (Zip Code)

(617) 926-5000

(Registrant’s Telephone Number, Including Area Code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

The annual meeting of stockholders of pSivida Corp. (the “Company”) was held on December 18, 2013. The stockholders elected each of the Company’s nominees for director, approved the stock option grant to the Company’s Chief Executive Officer, approved the stock option grants to the Company’s non-executive directors, ratified the issuance of common stock in July 2013, approved, on an advisory basis, the Company’s 2013 executive compensation, approved the option of one year as the frequency with which stockholders are provided an advisory vote on executive compensation and ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2014. The proposals below are described in detail in the Company’s definitive proxy statement filed with the SEC on October 25, 2013.

The results are as follows:

 

1. Election of Directors.

 

DIRECTOR NOMINEE    FOR      WITHHELD      NON VOTE  

David J. Mazzo

     7,779,568         131,070         9,671,020   

Paul Ashton

     7,779,918         128,220         9,673,520   

Douglas Godshall

     7,780,711         129,927         9,671,020   

Paul A Hopper

     7,421,533         486,605         9,673,520   

Michael Rogers

     7,711,143         199,495         9,671,020   

Peter G. Savas

     7,711,126         199,412         9,671,120   

 

2. Approval of stock option grant to the Company’s Chief Executive Officer.

 

FOR

     6,032,320   

AGAINST

     913,251   

ABSTAIN

     526,802   

NON VOTES

     9,673,950   

 

3. Approval of stock option grant to the following non-executive directors.

 

DIRECTOR    FOR      AGAINST      ABSTAIN      NON VOTES  

Douglas Godshall

     4,190,850         3,095,913         188,540         9,671,020   

Paul A. Hopper

     4,192,465         3,094,298         188,540         9,671,020   

Michael Rogers

     4,192,897         3,093,866         188,540         9,671,020   

Peter G. Savas

     4,191,615         3,095,798         187,890         9,671,020   

David J Mazzo

     4,187,572         3,099,191         188,540         9,671,020   


4. For purposes of ASX Listing Rule 7.4. ratification of the issuance and sale of 3,494,550 shares of common stock in July 2013.

 

FOR

     7,479,934   

AGAINST

     272,117   

ABSTAIN

     158,450   

NON VOTES

     9,671,157   

 

5. Advisory vote on the Company’s 2013 executive compensation

 

FOR

     7,323,951   

AGAINST

     474,104   

ABSTAIN

     112,583   

NON VOTES

     9,671,020   

 

6. Advisory vote on the frequency of future advisory votes

 

1 Year

     6,480,000   

2 Years

     39,042   

3 Years

     838,950   

ABSTAIN

     525,713   

NON VOTES

     9,697,953   

 

7. Ratification of the appointment of Deloitte & Touche LLP.

 

FOR

     17,212,502   

AGAINST

     58,135   

ABSTAIN

     308,521   


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      PSIVIDA CORP.
Date: December 23, 2013     By:  

/s/ Lori Freedman

      Lori Freedman, Vice President, Corporate Affairs, General Counsel and Secretary